Skip to main content

Table 1 Characteristics of study participants

From: Antihyperglycemic effect of short-term arginyl-fructose supplementation in subjects with prediabetes and newly diagnosed type 2 diabetes: randomized, double-blinded, placebo-controlled trial

 

Placebo (n = 24)

Test (n = 25)

Age (years)

58.3 ± 1.27

56.6 ± 1.98

Sex (male/female)

(19/5)

(19/6)

Weight (kg)

  

 0 week

65.9 ± 2.25

70.3 ± 1.92

 6 week

65.3 ± 2.25**

69.67 ± 1.86**

BMI (kg/m2)

  

 0 week

23.4 ± 0.67

24.9 ± 0.57

 6 week

23.2 ± 0.67**

24.7 ± 0.55**

WHR (cm/cm)

  

 0 week

0.89 ± 0.01

0.92 ± 0.01

 6 week

0.89 ± 0.01

0.92 ± 0.01

Body fat (%)

  

 0 week

23.4 ± 1.44

26.1 ± 1.45

 6 week

22.7 ± 1.49**

26.1 ± 1.48

Lean body mass (kg)

  

 0 week

50.2 ± 1.55

51.9 ± 2.94

 6 week

50.1 ± 1.55

51.3 ± 1.57

Systolic BP

  

 0 week

128.6 ± 2.67

129.5 ± 2.94

 6 week

124.5 ± 2.99

128.2 ± 2.17

Diastolic BP

  

 0 week

77.9 ± 1.55

78.2 ± 1.85

 6 week

76.4 ± 1.70

78.2 ± 1.57

TEE (kcal/day)

  

 0 week

2123 ± 232.52

2266 ± 273.43

 6 week

2140 ± 229.63*

2280 ± 280.27

TCI (kcal/day)

  

 0 week

2241 ± 251.81

2288 ± 261.65

 6 week

2210 ± 261.45*

2266 ± 252.84*

Carbohydrate (%)

  

 0 week

61.9 ± 0.64

61.3 ± 0.81

 6 week

61.8 ± 0.79

61.3 ± 0.77

Protein (%)

  

 0 week

15.9 ± 0.38

16.0 ± 0.37

 6 week

15.8 ± 0.36

15.9 ± 0.38

Fat (%)

  

 0 week

22.9 ± 1.10

23.4 ± 1.25

 6 week

23.1 ± 1.12

23.4 ± 0.87

  1. Data are shown as mean ± SEM
  2. p < 0.1, *p < 0.05, **p < 0.01, compared to 0 week, tested by paired t-test
  3. BMI Body mass index, BP Blood pressure, TCI Total calorie intake, TEE Total energy expenditure, WHR Waist-to-hip ratio